The Society for Translational Oncology Fellows' Forum is accepting applications through July 31.
The DOD prostate cancer program seeks to focus applications and direct funding on four “overarching challenges” and seven “focus areas” to address critical needs in prostate cancer research and clinical management.
Stand Up To Cancer announced a second SU2C Catalyst collaboration with Genentech, a member of the Roche Group, aimed at accelerating the development of new cancer treatments and combination therapies through clinical trials using Genentech medicines, including both commercial and pre-commercial treatments.
Applications submitted to the FY17 research program must address at least one of the seven Areas of Emphasis listed below:
FY17 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.
FY17 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.
Due to the current Continuing Resolution, the Fiscal Year 2017 Defense Appropriations bill has not been passed.
The Department of Defense Prostate Cancer Research Program is pre-announcing the application process for its funding awards even though due to the current Continuing Resolution, the Fiscal Year 2017 Defense Appropriations bill has not been passed to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Stand Up To Cancer broke new ground today when the American Association for Cancer Research, its scientific partner, announced to the cancer research community funding to support new Dream Teams focused on “cancer interception” of the pancreas and lungs.
LUNGevity announced a request for applications for translational research for career development awards that will be granted in 2017.
